global vaccine equity global vaccine equity
Stories About

global vaccine equity

The Corbevax vaccine was invented at the Center for Vaccine Development at Texas Children's Hospital and intended for countries that couldn't get access to more expensive COVID vaccines. India has inoculated millions of teens with Corbevax (above, a vaccination drive for children ages 12-14 at a school in Bangalore) and on August 10 authorized the vaccine as a booster for adults. Manjunath Kiran/AFP via Getty Images hide caption

toggle caption
Manjunath Kiran/AFP via Getty Images

Whatever happened to the new no-patent COVID vaccine touted as a global game changer?

  • Download
  • <iframe src="https://www.npr.org/player/embed/1119947342/1120798785" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

People line up to receive a Pfizer COVID-19 vaccine dose during a mass vaccination campaign in Abidjan, Ivory Coast, in August 2021. Issouf Sanogo/Getty Images hide caption

toggle caption
Issouf Sanogo/Getty Images

Why this USAID official is optimistic the U.S. can get the world vaccinated

  • Download
  • <iframe src="https://www.npr.org/player/embed/1080707913/1080885001" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Dr. KJ Seung, a professor at Harvard Medical School, speaks at a September rally outside the home of the CEO of Moderna, maker of one of the two mRNA vaccines that prevent COVID-19. The fake bones are meant to represent lives lost unnecessarily to the coronavirus. Seung was part of a group of doctors demanding Moderna share vaccines — and its recipe — with low-resource countries. Jasper G. Goodman/The Harvard Crimson hide caption

toggle caption
Jasper G. Goodman/The Harvard Crimson